Germany's Genekam rolls out Wuhan coronavirus test

By LabPulse.com staff writers

February 4, 2020 -- Genekam Biotechnology has introduced a research-use-only real-time polymerase chain reaction (PCR) test specific for the novel coronavirus (2019-nCoV) that originated in China and has spread to 24 other countries as of February 4.

Genekam's test can be used to analyze oral, nasal, respiratory, and blood samples, according to the Duisburg, Germany-based company. Genekam also noted that it is developing a test that will be able to differentiate between 2019-nCoV and related coronaviruses, such as those that cause severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS).

Real-time PCR kit for 2019-nCoV
Real-time PCR kit for 2019-nCoV. Image courtesy of Genekam.

The company said it has developed treatments that might be effective for the Wuhan coronavirus and also is working on a preventive vaccine for 2019-nCoV and related viruses.

As of February 4, more than 20,600 cases of 2019-nCoV had been reported globally. The U.S. Food and Drug Administration has issued an emergency use authorization paving the way for use of the Centers for Disease Control and Prevention's own 2019-nCoV panel.

Wuhan coronavirus RT-PCR tests deliver results fast
Scientists in Hong Kong and China have developed rapid reverse transcription polymerase chain reaction (RT-PCR) tests that may be used to identify and...
FDA shares CDC test with labs on emergency use basis
In a breakthrough for diagnostics amid the Wuhan coronavirus crisis, the U.S. Food and Drug Administration (FDA) has issued an emergency use authorization...
Oxford Nanopore sends sequencers to China for coronavirus
Oxford Nanopore Technologies has shipped an additional 200 MinION sequencers and related consumables to China to support the ongoing surveillance of the...
Wuhan coronavirus spread may be vastly underestimated
Up to 75,815 people in the city of Wuhan, China, are estimated to be infected with the 2019 novel coronavirus (2019-nCoV), which is vastly more than official...
Laboratories, IVD vendors get to work on novel coronavirus
The emergence of novel viruses underscores the need for laboratories to be vigilant and for IVD vendors to constantly update test menus, writes Bruce...

Copyright © 2020 LabPulse.com

Last Updated np 2/4/2020 5:53:05 PM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current